Laboratory medicine 90046 - Beta 2 glycoprotein i(b2gpi)antibody screen

General Info

Billing Amount: $44.65


The following indications for this test include:
i) Patients with vascular thrombosis Ð one or more clinical episodes of arterial, venous or small vessel thrombosis in any tissue or organ. Thrombosis must be confirmed by objective validated criteria.
ii) Patients with pregnancy morbidity:
a) One or more unexplained deaths of a morphologically normal fetus at or beyond the 10th week of gestation, with normal fetal morphology documented by ultrasound or by direct examination of the fetus.
b) One or more premature births of a morphologically normal neonate before the 34th week of gestation because of: eclampsia or severe pre-eclampsia defined according to standard definitions or recognized features of placental insufficiency, or
c) Three or more unexplained consecutive spontaneous abortions before the 10th week of gestation, with maternal anatomic or hormonal abnormalities, and paternal and maternal chromosome causes excluded.

Not payable with P90047

Designated approved on a provisional basis awaiting further review.

Pre-Amble References:

Please reference the billing pre-amble for these relevant interpretations of this billing code:

See Pre-Amble Notes